These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 11253374)

  • 1. African and Asian women may be more susceptible to HIV-1.
    J Gend Specif Med; 2000; 3(6):12. PubMed ID: 11253374
    [No Abstract]   [Full Text] [Related]  

  • 2. Mathematical model offers clues to Africa epidemic.
    AIDS Alert; 2001 Nov; 16(11):149-50, 138. PubMed ID: 11692670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of the CCR5Delta32 mutation in Brazilian populations and cell susceptibility to HIV-1 infection.
    Grimaldi R; Shindo N; Acosta AX; Dourado I; Brites C; de Melo Carvalho O; Brito I; Bou-Habib DC; Galvão-Castro B
    Hum Genet; 2002 Jul; 111(1):102-4. PubMed ID: 12136242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of the HIV-1 protective Delta ccr5 allele in most ethnic populations of India.
    Majumder PP; Dey B
    Eur J Hum Genet; 2001 Oct; 9(10):794-6. PubMed ID: 11781692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One copy of mutation may help resistance: study.
    AIDS Alert; 2002 Feb; 17(2):23-4, 14. PubMed ID: 11862745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCR5 mutations and HIV susceptibility.
    HIV Hotline; 1998 Mar; 8(1):15. PubMed ID: 11365356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility to HIV infection--disentangling host genetics and host behavior.
    Telenti A; Ioannidis JP
    J Infect Dis; 2006 Jan; 193(1):4-6. PubMed ID: 16323124
    [No Abstract]   [Full Text] [Related]  

  • 8. The Black Death and AIDS: CCR5-Delta32 in genetics and history.
    Cohn SK; Weaver LT
    QJM; 2006 Aug; 99(8):497-503. PubMed ID: 16880184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV/AIDS. HIV: experiencing the pressures of modern life.
    Nolan D; James I; Mallal S
    Science; 2005 Mar; 307(5714):1422-4. PubMed ID: 15746416
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety in numbers.
    Melief CJ
    Eur J Hum Genet; 2005 Jul; 13(7):795-6. PubMed ID: 15886714
    [No Abstract]   [Full Text] [Related]  

  • 11. The frequency of CCR5Delta32 and CCR2-64I in southern Iranian normal population.
    Gharagozloo M; Doroudchi M; Farjadian S; Pezeshki AM; Ghaderi A
    Immunol Lett; 2005 Jan; 96(2):277-81. PubMed ID: 15585333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 32-nucleotide deletion, associated with defence against hiv/aids, is a predominant mutation of CCR5 gene in the population of Georgia.
    Kamkamidze G; Capoulade-Metay C; Butsashvili M; Dudoit Y; Chubinishvili O; Debre P; Theodorou L
    Georgian Med News; 2005 Jan; (118):74-9. PubMed ID: 15821335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of CCR5 genotypes and HLA Class I B alleles in HIV-1 infected and uninfected injecting drug users from Rio de Janeiro, Brazil.
    Teixeira SL; Bastos FI; Hacker MA; Morgado MG
    Infect Genet Evol; 2009 Jul; 9(4):638-42. PubMed ID: 19460331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of CCR5 gene 32-basepair deletion in Croatian normal population.
    Ristić S; Starcević Cizmarević N; Brajenović-Milić B; Crnić-Martinović M; Kapović M
    Croat Med J; 2005 Aug; 46(4):693-4. PubMed ID: 16100775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCR5 promoter polymorphisms and HIV-1 perinatal transmission in Brazilian children.
    de Souza PR; Arraes LC; de Lima Filho JL; Bruneska D; Milanese M; Crovella S
    J Reprod Immunol; 2006 Feb; 69(1):77-84. PubMed ID: 16233918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of CCR5-delta32, CCR2-64I and SDF-1-3'A polymorphic alleles on human immunodeficiency virus 1 (HIV-1) infection in the Polish population].
    Wasik TJ; Smoleń J; Kruszyński P; Bratosiewicz-Wasik J; Beniowski M
    Wiad Lek; 2005; 58(9-10):500-7. PubMed ID: 16529059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural selection and resistance to HIV.
    Schliekelman P; Garner C; Slatkin M
    Nature; 2001 May; 411(6837):545-6. PubMed ID: 11385558
    [No Abstract]   [Full Text] [Related]  

  • 18. Host genetic background at CCR5 chemokine receptor and vitamin D receptor loci and human immunodeficiency virus (HIV) type 1 disease progression among HIV-seropositive injection drug users.
    Barber Y; Rubio C; Fernández E; Rubio M; Fibla J
    J Infect Dis; 2001 Nov; 184(10):1279-88. PubMed ID: 11679916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic influence of CCR5, CCR2, and SDF1 variants on human immunodeficiency virus 1 (HIV-1)-related disease progression and neurological impairment, in children with symptomatic HIV-1 infection.
    Singh KK; Barroga CF; Hughes MD; Chen J; Raskino C; McKinney RE; Spector SA
    J Infect Dis; 2003 Nov; 188(10):1461-72. PubMed ID: 14624371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the CCR5-Delta32 HIV resistance allele and new mutations of the CCR5 gene in different Tunisian populations.
    Jlizi A; Edouard J; Fadhlaoui-Zid K; Frigi S; Debré P; Slim A; Theodorou I; El Gaaied AB; Carpentier W
    Hum Immunol; 2007 Dec; 68(12):993-1000. PubMed ID: 18191728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.